An, Ping http://orcid.org/0000-0002-5322-3510
Sezgin, Efe http://orcid.org/0000-0002-8000-7485
Kirk, Gregory D.
Duggal, Priya http://orcid.org/0000-0001-5809-2081
Binns-Roemer, Elizabeth
Nelson, George
Limou, Sophie
Van Natta, Mark L.
Jabs, Douglas A.
Estrella, Michelle
Kopp, Jeffrey B. http://orcid.org/0000-0001-9052-186X
Winkler, Cheryl A. http://orcid.org/0000-0001-5552-0917
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (HHSN261200800001E, HHSN261200800001E)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 8 September 2020
Accepted: 8 February 2021
First Online: 5 March 2021
Competing interests
: E.M. declares involvement in an Aztra Zeneca Design and Delivery Advisory Board specifically related to APOL1 and has not received any funds or any other forms of compensation. The remaining authors declare no competing interests.